Related Experiment Video

Updated: Jan 28, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

883

The effect of aldose reductase inhibition by JMC-2004 on hyperglycemia-induced endothelial dysfunction

Ivana Papezikova1, Michaela Pekarova, Maria Chatzopoulou

  • 1Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic. ivanah@ibp.cz

Neuro Endocrinology Letters
|November 7, 2008
PubMed
Abstract

Insights

A novel aldose reductase (ALR-2) inhibitor, JMC-2004, effectively reversed hyperglycemia-induced endothelial dysfunction in bovine aortic endothelial cells by restoring nitric oxide production.

Area of Science:

  • Biochemistry
  • Vascular Biology
  • Diabetic Complications

Background:

  • Increased glucose utilization via aldose reductase (ALR-2) contributes to diabetic vascular complications.
  • This process involves cofactor depletion, impacting antioxidant enzymes and endothelial nitric oxide synthase (eNOS).

Purpose of the Study:

  • To investigate the therapeutic potential of JMC-2004, a novel ALR-2 inhibitor, against hyperglycemia-induced endothelial dysfunction.

Main Methods:

  • Bovine aortic endothelial cells (BAEC) were exposed to high glucose (30 mM) with or without JMC-2004.
  • Nitric oxide (NO) production was measured after stimulation with calcium ionophore A23187.
  • Antioxidant capacity and eNOS expression were also assessed.

Main Results:

  • High glucose significantly reduced NO production in BAEC.
  • JMC-2004 treatment restored NO production by 40% without altering eNOS expression.
  • JMC-2004 demonstrated high selectivity for ALR-2 and lacked antioxidant activity.

Conclusions:

  • Inhibition of ALR-2 with JMC-2004 effectively ameliorated hyperglycemia-induced endothelial dysfunction in BAEC.
  • JMC-2004 represents a promising therapeutic strategy for diabetic vascular complications.

More Related Videos

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

5.5K
Acute and Chronic Models of Hyperglycemia in Zebrafish: A Method to Assess the Impact of Hyperglycemia on Neurogenesis and the Biodistribution of Radiolabeled Molecules13:35

Acute and Chronic Models of Hyperglycemia in Zebrafish: A Method to Assess the Impact of Hyperglycemia on Neurogenesis and the Biodistribution of Radiolabeled Molecules

Published on: June 26, 2017

13.9K

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.9K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.2K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Induced-fit Model01:13

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K